Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

E-Poster Display

1580P - Fear of cancer recurrence among young adult cancer survivors: Exploring long-term contributing factors in a large, population-based cohort

Date

17 Sep 2020

Session

E-Poster Display

Topics

Psychosocial Aspects of Cancer

Tumour Site

Presenters

Kathrine Vandraas

Citation

Annals of Oncology (2020) 31 (suppl_4): S898-S902. 10.1016/annonc/annonc286

Authors

K. Vandraas1, K.V. Reinertsen1, C. Kiserud1, H.C. Lie2

Author affiliations

  • 1 National Advisory Unit For Late Effects After Cancer, Oncology Department, Oslo University Hospital - The Norwegian Radium Hospital, 0424 - Oslo/NO
  • 2 Department Of Behavioral Sciences In Medicine, Institute Of Basic Medical Sciences, University of Oslo, Oslo/NO

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 1580P

Background

Fear of cancer recurrence (FCR) may be debilitating, yet knowledge of FCR among the growing population of long-term young adult survivors (YACS) is scarce. We explored risk of FCR and associated factors in a nation-wide, population-based cohort of YACS.

Methods

All 5-year survivors diagnosed at the ages of 19-39 years with breast cancer (BC), malignant melanoma (MM), colorectal cancer (CRC), acute lymphatic leukemia (ALL) and non-Hodgkin lymphoma (NHL) during 1985-2009 in Norway, were identified by the Cancer Registry of Norway (CRN) and completed the cross-sectional comprehensive NOR-CAYACS health survey. Group comparisons were performed using ANOVA. Univariate and multivariate linear regression modelling was performed.

Results

In total, 936 YACs were included in the study, with an average of 16 years since diagnoses. Survivors worried most about getting another cancer (74%). One in five reported quite a bit or a lot of FCR. BC and MM survivors had the highest FCR scores. Post-traumatic stress symptoms (PTSS) had the strongest association with FCR, over and above demographic and clinical variables.

Conclusions

This is the first study to demonstrate that FCR is prevalent among YACs even decades beyond treatment completion, including survivors of MM with favorable prognoses. Attention to ongoing risks of PTSS and FCR in this growing survivor population is warranted to optimize future survivorship care.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

National advisory unit of late effects after cancer treatment, Oslo University Hospital, Oslo, Norway.

Funding

The Norwegian Cancer Society (45980) and The Norway Research Council (218312).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.